The findings could enable earlier detection and treatment for people affected by the serious eye condition. A research team ...

Two sustained-release procedural pharmaceuticals or drug-delivery options are available in the US: the bimatoprost ...

Artificial intelligence (AI) might be able to help doctors make glaucoma screening widely available, a new study says.

Please provide your email address to receive an email when new articles are posted on . Glaucoma may be a result of two pressures: IOP and intracranial pressure. When one pressure is high and the ...

Proactive strategies in glaucoma care, including minimally invasive glaucoma surgery (MIGS) and physician decision-making, ...

Shuchi Patel, MD: Good afternoon, Dr. Ruth Williams. Thank you so much for taking the time to have a discussion with us regarding a topic that is of emerging interest. Today we're going to talk about ...

Nova Eye Medical Ltd (($ELXMF)) announced an update on their ongoing clinical study. Study Overview: The study titled ‘Multicenter Glaucoma Study ...

A licensing agreement between SERI and Eyexora Global has launched Y.ora Vision, a new ophthalmic medical device company.

Please provide your email address to receive an email when new articles are posted on . Greater variability of blood pressure over time was linked to faster visual field progression in patients with ...

Fluctuations in blood pressure over an extended period, along with their interaction with mean blood pressure or intraocular pressure, are associated with a more rapid visual field progression in ...

Inflammatory glaucoma, also known as uveitic glaucoma, is a complication of uveitis. It occurs when inflammation in the eye increases intraocular pressure and damages the optic nerve. Inflammatory ...

In pseudoexfoliation glaucoma, an accumulation of protein-like flakes forms in the eye. The buildup of protein clogs the eye’s drainage system, leading to increased pressure in the eye. Glaucoma is a ...